Research output per year
Research output per year
Personal profile
Overview
Azadeh is a research associate at the University of Manchester based at the Christie NHS Foundation Trust. Her current project is identifying patients that are at high risk of cardiopulmonary toxicity following thoracic radiotherapy by utilizing data-mining approaches.
She is interested in pre-existing multimorbidity big data analysis, and treatment related haematological toxicity in patients with cancer.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research Beacons, Institutes and Platforms
- Manchester Cancer Research Centre
Fingerprint
Dive into the research topics where Azadeh Abravan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Radiotherapy-related lymphopenia affects overall survival in patients with lung cancer
Abravan, A., Faivre-Finn, C., Kennedy, J., McWilliam, A. & van Herk, M., 14 Jun 2020, (E-pub ahead of print) In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.Research output: Contribution to journal › Article › peer-review
Open AccessFile9 Downloads (Pure) -
Qualitative study on diversity, equity, and inclusion within radiation oncology in Europe
Abravan, A., Correia, D., Gasnier, A., Shakhverdian, S., van der Stok, T., Bertholet, J., Dubois, L. J., Jereczek-Fossa, B. A., Eng, M. P., Spalek, M., Petit, S. F., Franco, P. & Petit-Steeghs, V., 2023, In: International Journal of Radiation: Oncology - Biology - Physics.Research output: Contribution to journal › Article › peer-review
-
Effect of systemic inflammation biomarkers on overall survival after lung cancer radiotherapy: a single-center large-cohort study
Abravan, A., Salem, A., Price, G., Faivre-Finn, C. & van Herk, M., 1 Feb 2022, In: Acta oncologica (Stockholm, Sweden). 61, 2, p. 163-171 9 p.Research output: Contribution to journal › Article › peer-review
-
Heart dose and cardiac comorbidities influence death with a cardiac cause following hypofractionated radiotherapy for lung cancer
Banfill, K., Abravan, A., van Herk, M., Sun, F., Franks, K., McWilliam, A. & Faivre-Finn, C., 2022, In: Frontiers in Oncology. 12, p. 1007577Research output: Contribution to journal › Article › peer-review
-
Role of Real-World Data in Assessing Cardiac Toxicity After Lung Cancer Radiotherapy
Abravan, A., Price, G., Banfill, K., Merchant, T., Craddock, M., Wood, J., Aznar, M. C., Mcwilliam, A., Van Herk, M. & Faivre-Finn, C., 13 Jun 2022, (Accepted/In press) In: Frontiers in Oncology.Research output: Contribution to journal › Article › peer-review
Press/Media
-
Research at The Christie could extend lung cancer survival
8/05/19
1 item of Media coverage
Press/Media: Research